Trillium tschonoskii maxim extract attenuates abnormal Tau phosphorylation

• Published in: Neural regeneration research 2018-05, Vol.13 (5), p.915-922
• Main Authors: Luo, Hong-Bin, Shang, Nan, Xie, Wen-Zhi, Wen, De-Jian, Qu, Min, Huang, Sheng, Fan, Sha-Sha, Chen, Wei, Mou, Nan-Qiao, Liu, Xiang-Yu, Chen, Qin, Xie, Feng-Feng, Li, Jun-Xu
• Format: Article
• Language: English
• Subjects: Alzheimer's disease; Analysis; Animal behavior; Brain; Care and treatment; Disease; Genetic aspects; Infrared imaging systems; Laboratory animals; Memory; nerve regeneration; Trillium tschonoskii maxim; homocysteine; Alzheimer′s disease; cognitive disorders; Tau; synaptic development; neural regeneration; Phosphorylation; Physiological aspects; Polyclonal antibodies; Proteins; Risk factors; Rodents; Traditional Chinese medicine; Trilliums
• ISSN: 1673-5374; 1876-7958
• DOI: 10.4103/1673-5374.232487

Large-scale epidemiological studies have found that hyperhomocysteinemia is a powerful, independent risk factor for Alzheimer's disease. Trillium tschonoskii maxim is a traditional Chinese medicine that is used to promote memory. However, scientific understanding of its mechanism of action is limited. This report studied the potential neuroprotective effects of Trillium tschonoskii maxim extract against homocysteine-induced cognitive deficits. Rats were intravenously injected with homocysteine (400 μg/kg) for 14 days to induce a model of Alzheimer's disease. These rats were then intragastrically treated with Trillium tschonoskii maxim extract (0.125 or 0.25 g/kg) for 7 consecutive days. Open field test and Morris water maze test were conducted to measure spontaneous activity and learning and memory abilities. Western blot assay was used to detect the levels of Tau protein and other factors involved in Tau phosphorylation in the hippocampus. Immunohistochemical staining was used to examine Tau protein in the hippocampus. Golgi staining was applied to measure hippocampal dendritic spines. Our results demonstrated that homocysteine produced learning and memory deficits and increased levels of Tau phosphorylation, and diminished the activity of catalytic protein phosphatase 2A. The total number of hippocampal dendritic spines was also decreased. Trillium tschonoskii maxim extract treatment reversed the homocysteine-induced changes. The above results suggest that Trillium tschonoskii maxim extract can lessen homocysteine-induced abnormal Tau phosphorylation and improve cognitive deterioration such as that present in Alzheimer's disease.